The global preterm birth control market is expected to reach US$ 1,809.0 Mn in 2025 from US$ 1,190.5 Mn in 2017. The market is estimated to grow with a CAGR of 4.9% from 2018-2025.
North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant rate in Asia Pacific (APAC) region during the forecast period. The Asia Pacific per-term birth control market is expected to grow with CAGR of 5.1% to US$ 325.6 Mn in 2025 from US$ 222.4 Mn in 2017.
Lucrative Regional Markets
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
Increasing Number of Preterm Births
There has been a gradual increase in the number of preterm births from last few years. As per the World Health Organization (WHO), premature birth is a leading cause of death among the child below 5 years of age. It may be due to early induction of labor or caesarean birth. Multiple pregnancies, infections and chronic conditions such as diabetes and high blood pressure are others common causes of preterm births. As per the Centers for Disease Control and Prevention (CDC), reduction in preterm birth was observed from 2007-2014. In 2015, low birth weight and preterm birth accounted for about 17% of infant deaths. However, the number increased during 2016, with racial and ethnic differences. In the US, 1 of every 10 infants born was a preterm birth.
Initiatives towards Prevention of Preterm Birth
A number of government and non-government organizations are engaged increasing awareness about preterm birth in various countries across the globe. Organizations such as CDC has implemented strategies to reduce preterm births. These strategies includes provision of healthcare services before and between pregnancies; determining population at the risk of preterm delivery and provide immediate treatment, discouraging deliveries before 39 weeks without a medical need; and preventing unintended pregnancies by waiting for at least 18 months between pregnancies.
Stringent Regulatory Framework
Regulatory authorities such as Food & Drug Administration (FDA), European Medicine Agency (EMA) and others has consistently shown a tough stance towards pharmaceutical can biotechnology manufacturers. The market players must comply with the requirement and guidelines of FDA and other regulatory authorities and should constantly keep a check over time to time changes made in these guidelines. The manufacturers of pharmaceutical drugs and medical devices must abide by these regulations pertaining to current good manufacturing practices (cGMP) as well as good laboratory practices (GLP) in order to assure proper design, monitoring, and control of manufacturing processes and facilities. Furthermore, any deviations from the registered protocols, demands and requirements of these guidance leads to termination of the clinical trials undertaken by the pharmaceutical companies.
Additionally, FDA also requires strong safety monitoring and a strict dispensing plan to be followed by the manufacturer. Non-compliance by the manufacturers affects the sales of the products in the market and may lead to the recalls for marketed products due to instances recorded for deficit of the promises in the function and performance of the product or therapeutic may tarnish the company’s reputation risking its future growth. In case of clinical trials for development of therapeutics for preterm birth control, the FDA and other regulatory bodies have strict regulations due to which it is difficult for the manufacturers to pool in pregnant patients generating lack of working models. This in turn results into rejection of trials and can thus act as hindrance to the market growth.
Product Insights
The pre-term birth control market by treatment method is segmented into pharmaceutical treatment and devices. The pharmaceutical treatment segment is poised to grow with a largest market share of 55.6% in 2017. The market for pharmaceutical treatment is anticipated to surge during the forecast period from 2017 to 2025, at a significant rate.
Pre-term birth control Market, by Treatment method
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Preterm Birth Control Market: Strategic Insights
Market Size Value in US$ 1,190.5 Million in 2017 Market Size Value by US$ 1,809.0 Million by 2025 Growth rate CAGR of 4.9% from 2018-2025 Forecast Period 2018-2025 Base Year 2018
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Preterm Birth Control Market: Strategic Insights
| Market Size Value in | US$ 1,190.5 Million in 2017 |
| Market Size Value by | US$ 1,809.0 Million by 2025 |
| Growth rate | CAGR of 4.9% from 2018-2025 |
| Forecast Period | 2018-2025 |
| Base Year | 2018 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Collaborations/ acquisitions were observed as the most adopted strategy in global pre-term birth control industry. Few of the product launches and agreements made by the players in the market are listed below;
2018: CooperSurgical had acquired the assets of The LifeGlobal Group and its affiliates. The LifeGlobal Group is a leading global provider of in-vitro fertilization devices.
PRE-TERM BIRTH CONTROL – MARKET SEGMENTATION
By Treatment method
- Devices
- Cervical Cerclage
- Vaginal Pessaries
- Pharmaceutical treatment
By Geography
- North America
- US
- Canada
- Mexico
- Europe
- France
- Germany
- U.K
- Asia Pacific
- Japan
- China
- India
- Middle East & Africa
- UAE
- Saudi Arabia
- South Africa
- South & Central America
- Argentina
- Brazil
Company Profiles
- Cooper Surgical
- Medgyn Products
- Integra Life sciences Corporation
- Panpac Medical Corp.
- Dr. Arabin GMBH & Co. KG
- Amag Pharmaceuticals
- Ben Way Enterprises Sdn Bhd
- Personal Medical Corp.
- Bioteque America Inc.
- Bliss Gvs Pharma Ltd.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Treatment Method , and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
US, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina
1. INTRODUCTION
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
2. Global Preterm birth control Market – Key takeaways
3. Global preterm birth control Market – market landscape
3.1 overview
3.2 market segmentation
3.2.1 Global Preterm Birth Control Market – By Treatment Method
3.2.2 Global Preterm Birth Control Market – By Geography
3.3 PEST Analysis
3.3.1 North America – PEST Analysis
3.3.2 Europe– PEST Analysis
3.3.3 Asia Pacific – PEST Analysis
3.3.4 Middle East And Africa– PEST Analysis
3.3.5 South and Central America – PEST Analysis
4. Global Preterm birth control market – Key Market Dynamics
4.1 Key Market Drivers
4.1.1 Increasing Number of Preterm Births
4.1.2 Initiatives Towards Prevention of Preterm Birth
4.2 Key Market Restraints
4.2.1 Stringent Regulatory Framework
4.3 Key Market Opportunities
4.3.1 Growth of Pharmaceutical Industry
4.3.2 Increasing Healthcare Expenditure in Emerging Markets
4.4 Future Trends
4.4.1 Uses Nanotechnology to Prevent Preterm Birth
4.5 Impact analysis
5. PRETERM BIRTH CONTROL Market – Global Analysis
5.1 global PRETERM BIRTH CONTROL Market Revenue Forecasts and Analysis
5.2 global PRETERM BIRTH CONTROL Market, By Geography - Forecasts and Analysis
5.3 expert opinions
6. Preterm Birth Control market analysis– by Treatment method
6.1 overview
6.2 Devices MARKET
6.2.1 Overview
6.2.2 Global Devices Market Revenue and Forecasts to 2025 (US$ Mn)
6.2.3 Cervical Cerclage Devices Market
6.2.3.1 Overview
6.2.3.2 Global Cervical Cerclage Devices Market Revenue and Forecasts to 2025 (US$ Mn)
6.2.4 Vaginal Pessaries Market
6.2.4.1 Overview
6.2.4.2 Global Vaginal Pessaries Market Revenue and Forecasts to 2025 (US$ Mn)
6.3 Pharmaceutical Treatment MARKET
6.3.1 Overview
6.3.2 Global Pharmaceutical Treatment Market Revenue and Forecasts to 2025 (US$ Mn)
7. North America Preterm birth control Market Revenue and Forecasts to 2025
7.1 Overview
7.2 North America Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
7.3 North America Preterm birth control Market Revenue And Forecasts to 2025, By Treatment method (US$ Mn)
7.3.1 North America Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
7.4 North America Preterm birth control Market Revenue And Forecasts to 2025, By Country (%)
7.5 US Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
7.5.1 US Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
7.5.2 US Preterm Birth Control Market Revenue And Forecasts to 2025, By Treatment Method(US$ Mn)
7.5.2.1 US Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
7.6 Canada Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
7.6.1 Canada Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
7.6.2 Canada Preterm Birth Control Market Revenue And Forecasts to 2025, By Treatment Method (US$ Mn)
7.6.2.1 Canada Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
7.7 Mexico Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
7.7.1 Mexico Preterm Birth Control Market Revenue and Forecasts to 2025 (US$ Mn)
7.7.2 Mexico Preterm Birth Control Market Revenue And Forecasts to 2025, By Treatment Method (US$ Mn)
7.7.2.1 Mexico Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
8. Europe preterm birth control Market Revenue and Forecasts to 2025
8.1 Overview
8.2 Europe Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
8.3 Europe Preterm birth control Market Revenue And Forecasts to 2025, By Treatment method (US$ Mn)
8.3.1 Europe Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
8.4 Europe Preterm birth control Market Revenue And Forecasts to 2025, By Country (%)
8.5 Germany Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
8.5.1 Germany Preterm Birth Control Market Revenue and Forecasts to 2025 (US$ Mn)
8.5.2 Germany Preterm Birth Control Market Revenue And Forecasts to 2025, By Treatment Method (US$ Mn)
8.5.2.1 Germany Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
8.6 UK Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
8.6.1 UK Preterm Birth Control Market Revenue and Forecasts to 2025 (US$ Mn)
8.6.2 UK Preterm Birth Control Market Revenue And Forecasts to 2025, By Treatment Method (US$ Mn)
8.6.2.1 UK Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
8.7 France Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
8.7.1 France Preterm Birth Control Market Revenue and Forecasts to 2025 (US$ Mn)
8.7.2 France Preterm Birth Control Market Revenue And Forecasts to 2025, By Treatment Method (US$ Mn)
8.7.2.1 France Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
9. Asia pacific Preterm birth control Market Revenue and Forecasts to 2025
9.1 Overview
9.2 asia pacific Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
9.3 Asia Pacific Preterm birth control Market Revenue And Forecasts to 2025, By Treatment Method (US$ Mn)
9.3.1 Asia Pacific Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
9.4 Asia Pacific Preterm birth control Market SHARE BY COUNTRY, 2017 AND 2025 (%)
9.5 China Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
9.5.1 China Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
9.5.2 China Preterm Birth Control Market Revenue And Forecasts to 2025, By Treatment Method (US$ Mn)
9.5.2.1 China Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
9.6 Japan Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
9.6.1 Japan Preterm Birth Control Market Revenue and Forecasts to 2025 (US$ Mn)
9.6.2 Japan Preterm Birth Control Market Revenue And Forecasts to 2025, By Treatment Method (US$ Mn)
9.6.2.1 Japan Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
9.7 India Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
9.7.1 India Preterm Birth Control Market Revenue and Forecasts to 2025 (US$ Mn)
9.7.2 India Preterm Birth Control Market Revenue And Forecasts to 2025, By Treatment Method (US$ Mn)
9.7.2.1 India Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
10. Middle East and Africa Preterm birth control Market Revenue and Forecasts to 2025
10.1 Overview
10.2 Middle East and Africa Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
10.3 Middle East and Africa Preterm birth control Market Revenue And Forecasts to 2025, By Treatment Method (US$ Mn)
10.3.1 Middle East and Africa Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
10.4 Middle East and Africa Preterm birth control Market SHARE BY COUNTRY, 2017 AND 2025 (%)
10.5 UAE Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
10.6 UAE Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
10.6.1 UAE Preterm Birth Control Market Revenue And Forecasts to 2025, By Treatment Method (US$ Mn)
10.6.1.1 UAE Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
10.7 Saudi Arabia Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
10.8 Saudi Arabia Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
10.8.1 Saudi Arabia Preterm Birth Control Market Revenue And Forecasts to 2025, By Treatment Method (US$ Mn)
10.8.1.1 Saudi Arabia Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
10.9 South Africa Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
10.10 South Africa Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
10.10.1 South Africa Preterm Birth Control Market Revenue And Forecasts to 2025, By Treatment Method (US$ Mn)
10.10.1.1South Africa Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
11. south and central america preterm birth control Market Revenue and Forecasts to 2025
11.1 Overview
11.2 South and Central America Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
11.3 South and Central America Preterm birth control Market Revenue And Forecasts to 2025, By Treatment method (US$ Mn)
11.3.1 South and Central America Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
11.4 South and Central America Preterm birth control Market SHARE BY COUNTRY, 2017 AND 2025 (%)
11.5 Brazil Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
11.5.1 Brazil Preterm Birth Control Market Revenue and Forecasts to 2025 (US$ Mn)
11.5.2 Brazil Preterm Birth Control Market Revenue And Forecasts to 2025, By Treatment Method (US$ Mn)
11.5.2.1 Brazil Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
12. PRETERM BIRTH CONTROL MARKET–KEY COMPANY PROFILES
12.1 CooperSurgical, Inc.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Financial Overview
12.1.4 Product Portfolio
12.1.5 Swot Analysis
12.1.6 Key Developments
12.2 MEDGYN PRODUCTS, INC.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Financial Information
12.2.4 Product Portfolio
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Integra LifeSciences Corporation
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Financial Overview
12.3.4 Product Portfolio
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Panpac Medical Corp.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Financial Information
12.4.4 Product Portfolio
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Dr. Arabin GmbH & Co. KG
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Financial Information
12.5.4 Product Portfolio
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 AMAG Pharmaceuticals
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Financial Overview
12.6.4 Product Portfolio
12.6.5 Swot Analysis
12.6.6 Key Developments
12.7 BEN WAY ENTERPRISES SDN BHD
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Financial Overview
12.7.4 Product Portfolio
12.7.5 Swot Analysis
12.7.6 Key Developments
12.8 Personal Medical Corp.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Financial Overview
12.8.4 Product Portfolio
12.8.5 Swot Analysis
12.8.6 Key Developments
12.9 Bioteque America, Inc.
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Financial Overview
12.9.4 Product Portfolio
12.9.5 Swot Analysis
12.9.6 Key Developments
12.10 Bliss GVS Pharma Ltd.
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Financial Overview
12.10.4 Product Portfolio
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
13.3 Methodology
13.3.1 Coverage
13.3.2 Secondary Research
13.3.3 Primary Research
LIST OF TABLES
TABLE 1. preterm births by countires, 2015
TABLE 2. North America Preterm birth control Market Revenue And Forecasts to 2025, By Treatment Type (US$ Mn)
TABLE 3. North America Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
TABLE 4. Investments for preterm birth control studies
TABLE 5. US Preterm birth control Market Revenue And Forecasts to 2025, By Treatment Method (US$ Mn)
TABLE 6. US Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
TABLE 7. Canada Preterm birth control Market Revenue And Forecasts to 2025, By Treatment Method (US$ Mn)
TABLE 8. Canada Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
TABLE 9. Mexico Preterm birth control Market Revenue And Forecasts to 2025, By Treatment Method (US$ Mn)
TABLE 10. Mexico Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
TABLE 11. Europe Preterm birth control Market Revenue And Forecasts to 2025, By Treatment method (US$ Mn)
TABLE 12. Europe Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
TABLE 13. Germany Preterm birth control Market Revenue And Forecasts to 2025, By Treatment Method (US$ Mn)
TABLE 14. Germany Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
TABLE 15. UK Preterm birth control Market Revenue And Forecasts to 2025, By Treatment Method (US$ Mn)
TABLE 16. UK Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
TABLE 17. France Preterm birth control Market Revenue And Forecasts to 2025, By Treatment Method (US$ Mn)
TABLE 18. France Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
TABLE 19. Asia Pacific Preterm birth control Market Revenue And Forecasts to 2025, By Treatment Method (US$ Mn)
TABLE 20. Asia Pacific Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
TABLE 21. China Preterm birth control Market Revenue And Forecasts to 2025, By Treatment Method (US$ Mn)
TABLE 22. China Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
TABLE 23. Japan Preterm birth control Market Revenue And Forecasts to 2025, By Treatment Method (US$ Mn)
TABLE 24. Japan Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
TABLE 25. India Preterm birth control Market Revenue And Forecasts to 2025, By Treatment Method (US$ Mn)
TABLE 26. India Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
TABLE 27. Middle East and Africa Preterm birth control Market Revenue And Forecasts to 2025, By Treatment Method (US$ Mn)
TABLE 28. Middle East and Africa Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
TABLE 29. Middle East and Africa Preterm birth control Market SHARE BY COUNTRY, 2017 AND 2025 (%)
TABLE 30. UAE Preterm birth control Market Revenue And Forecasts to 2025, By Treatment Method (US$ Mn)
TABLE 31. UAE Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
TABLE 32. Saudi Arabia Preterm birth control Market Revenue And Forecasts to 2025, By Treatment Method (US$ Mn)
TABLE 33. Saudi Arabia Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
TABLE 34. South Africa Preterm birth control Market Revenue And Forecasts to 2025, By Treatment Method (US$ Mn)
TABLE 35. South Africa Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
TABLE 36. South and Central America Preterm birth control Market Revenue And Forecasts to 2025, By Treatment method (US$ Mn)
TABLE 37. South and Central America Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
TABLE 38. Brazil Preterm birth control Market Revenue And Forecasts to 2025, By Treatment Method (US$ Mn)
TABLE 39. Brazil Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
TABLE 40. Glossary of Terms, Preterm birth control market
LIST OF FIGURES
FIGURE 1. Asia Pacific Preterm birth control market, Revenue (US$ Mn), By Geography 2018 & 2025
FIGURE 2. Global Preterm birth control Market By product, Market Share (%), 2017
FIGURE 3. Preterm birth control Market Segmentation
FIGURE 4. Preterm birth control Segmentation, by region
FIGURE 5. North America PEST Analysis
FIGURE 6. Europe PEST Analysis
FIGURE 7. Asia pacific PEST Analysis
FIGURE 8. South and central america PEST Analysis
FIGURE 9. Preterm Birth Control market impact analysis of driver and restraints
FIGURE 10. global PRETERM BIRTH CONTROL Market – Revenue Forecasts and Analysis – 2016- 2025
FIGURE 11. global PRETERM BIRTH CONTROL Market – by geography Forecasts and Analysis – 2017- 2025
FIGURE 12. global Preterm Birth Control market breakdown, by treatment method 2017 & 2025 (%)
FIGURE 13. global Devices market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 14. global Cervical Cerclage Devices market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 15. global Vaginal Pessaries market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 16. global Pharmaceutical Treatment market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 17. North America preterm birth control Market Overview, by Country (2017)
FIGURE 18. North America Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 19. North America Preterm birth control Market Revenue And Forecasts to 2025, By Country (%)
FIGURE 20. US preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 21. Canada Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 22. Mexico Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 23. Europe preterm birth control Market Overview, by Country (2017)
FIGURE 24. Europe Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 25. Europe Preterm birth control Market Revenue And Forecasts to 2025, By Country (%)
FIGURE 26. Germany Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 27. UK preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 28. France Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 29. Asia Pacific preterm birth control Market REVENUE, by Country, 2017 (US$ MN)
FIGURE 30. asia pacific Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 31. Asia Pacific Preterm birth control Market SHARE BY COUNTRY, 2017 AND 2025 (%)
FIGURE 32. China preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 33. Japan Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 34. India Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 35. Middle East and Africa preterm birth control Market REVENUE, by Country, 2017 (US$ MN)
FIGURE 36. Middle East and Africa Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 37. UAE Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 38. Saudi Arabia Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 39. South Africa Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 40. South and Central America preterm birth control Market REVENUE, by Country, 2017 (US$ MN)
FIGURE 41. South and Central America Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 42. South and Central America Preterm birth control Market SHARE BY COUNTRY, 2017 AND 2025 (%)
FIGURE 43. Brazil preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
The List of Companies
- CooperSurgical, Inc.
- MEDGYN PRODUCTS, INC.
- Integra LifeSciences Corporation
- Panpac Medical Corp.
- Personal Medical Corp
- Bioteque America, Inc.
- Bliss GVS Pharma Ltd.
- Dr. Arabin GmbH & Co. KG
- AMAG Pharmaceuticals
- BEN WAY ENTERPRISES SDN BHD
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Preterm Birth Control Market
Sep 2018
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Sep 2018
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2018
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2018
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2018
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2018
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2018
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Sep 2018
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)